AKT2 represses GSK3β activity by increasing the phosphorylation level of GSK3β protein at Ser9 residues [28], and has been reported to be upregulated in CRC tissues compared to normal colon mucosa and promote tumor progression [29, 30]. This evidence concerns the gene GSK3B and colorectal carcinoma.